What happens when you take phenytoin with folate?
Phenytoin (Dilantin, Phenytek) is one of the oldest and still most widely used anticonvulsants for focal and generalized tonic-clonic seizures. Its interaction with folate runs in both directions, and it is one of the better-documented drug-nutrient interactions in clinical neurology.
- Phenytoin lowers folate. The drug induces hepatic enzymes that speed the breakdown of folate, and it also interferes with the intestinal absorption of the polyglutamate folates found in most foods. Over weeks to months of therapy, the combined effect is a steady decline in folate measured in blood, red cells, and cerebrospinal fluid.
- Folate speeds phenytoin clearance. Folate appears to act as a cofactor in phenytoin metabolism. When a folate-deficient person is given supplemental folic acid, the liver clears phenytoin faster and the drug level in the blood can fall.
- That fall can let seizures return. In some people the drop in phenytoin level is large enough to allow breakthrough seizures. This is the part patients and even some clinicians miss: adding what feels like a harmless vitamin can quietly weaken seizure control.
- The kinetics make it hard to predict. Phenytoin follows nonlinear (Michaelis-Menten) pharmacokinetics, so a modest change in metabolism can produce a disproportionately large swing in blood level. This is why the effect of a folate change cannot be reliably guessed without checking a level.
Why is this important?
This interaction matters on both sides, and ignoring either one carries consequences.
From the seizure side, a meaningful drop in phenytoin level after starting folate is enough to push some well-controlled patients back into breakthrough seizures, which bring their own dangers: falls, accidents, status epilepticus, and loss of driving privileges. Several published case reports describe exactly this sequence — a patient stable on phenytoin starts folic acid, the level drops, and seizures return.
From the folate side, deficiency is not trivial. Low folate raises homocysteine (a cardiovascular risk factor), can contribute to macrocytic anemia, and may worsen mood and cognition. Most critically, low folate around conception sharply raises the risk of neural tube defects. Phenytoin is also independently associated with birth defects, including fetal hydantoin syndrome, so women of childbearing potential face a genuine dilemma: they need folate to protect a possible pregnancy, but how it is supplemented matters.
The takeaway is balance, not fear. Both undertreating folate and oversupplementing it without monitoring carry real risk — which is why this is a coordinate-and-monitor situation, not an avoid-at-all-costs one.
What should you do?
Before any change: If you are on phenytoin, tell your neurologist before you start or change a folic acid supplement, and let them get a baseline phenytoin blood level first. Do not add a supplement-strength dose on your own.
Every day: A routine over-the-counter multivitamin level of folic acid is generally tolerated, but it is still worth mentioning to your prescriber so they know what you are taking. Watch for layered exposure — B-complex products, prenatal vitamins, and many "energy" or "hair, skin and nails" formulas also contain folic acid.
After a change: Have your phenytoin level rechecked a few weeks after starting or changing folate, so a clearance shift is caught on a lab result rather than as a returning seizure. Because of phenytoin's nonlinear kinetics, even small adjustments can move the level more than expected.
If you could become pregnant, do not simply skip folate out of fear of this interaction — and equally, do not self-dose it. Plan folate and pregnancy with your neurologist and have your phenytoin levels monitored. Both errors carry consequences.
Which specific products are affected?
On the drug side, the interaction applies to all phenytoin products — Dilantin, Phenytek, generic phenytoin, and fosphenytoin (Cerebyx). Other enzyme-inducing anticonvulsants such as phenobarbital, carbamazepine, and primidone likely lower folate to a lesser extent as well.
On the supplement side, it applies to folic acid (the synthetic form), folinic acid (leucovorin), and L-methylfolate (5-MTHF, Deplin). Methylfolate may behave somewhat differently in the body, but it has not been shown to be safe at supplement strength with phenytoin without monitoring.
Folic acid is also hidden in many products people do not think of as supplements: B-complex tablets, prenatal vitamins, and combination beauty or energy formulas. In addition, fortified breakfast cereals, breads, and pastas in the US carry added folic acid. Routine dietary fortification on its own has not been shown to destabilize phenytoin, but stacking a supplement on top of that fortified baseline is what tips the balance.
The science behind it
A 1995 review in Annals of Pharmacotherapy (Lewis et al., PMID 8520091) pulled together the human studies and case reports and described the interaction as bidirectional: phenytoin depletes folate, and folate supplementation can lower phenytoin levels. A focused case report in Neurology in 2005 (Steinweg and Bentley, PMID 15955964) documented the clinically important direction directly — seizures following a fall in phenytoin level after oral folic acid was given.
Taken together these sources establish the mechanism and show that the seizure risk is real, but they describe it as a monitorable, manageable effect rather than a frequent catastrophe — which is why this interaction is best treated as moderate and handled with coordination and lab follow-up.
Frequently Asked Questions
Can I take a regular multivitamin while on phenytoin?
A routine multivitamin level of folic acid is generally tolerated. Mention it to your prescriber so it is on record, but it is the supplement-strength doses that warrant coordination and a follow-up level.
Will folate stop my seizure medicine from working?
Not on its own and not inevitably. Supplemental folate can speed phenytoin clearance and lower its blood level, and in some people that has been enough to allow seizures to return. The risk is managed by checking your phenytoin level after a change, not by avoiding folate entirely.
I'm planning a pregnancy — should I stop folate because of this?
No. Folate around conception protects against neural tube defects, and skipping it is its own serious risk. The answer is physician-guided folate dosing with phenytoin level monitoring, not avoidance.
How soon after changing folate should I have my level checked?
Your neurologist will typically want a baseline level beforehand and a repeat a few weeks after the change, so any shift in phenytoin clearance shows up on a lab result rather than as a returning seizure.
Does this apply to methylfolate as well as folic acid?
Methylfolate may behave somewhat differently in the body, but it has not been shown to be safe at supplement strength with phenytoin without monitoring, so treat it with the same caution.
Do fortified cereals and breads count?
Routine dietary fortification on its own has not been shown to destabilize phenytoin. The concern is layering a folic acid supplement on top of that fortified baseline.
Key takeaways
- Phenytoin and folate interact both ways: the drug depletes the vitamin, and the vitamin at supplement strength can speed clearance of the drug and lower seizure protection.
- Do not start or change a folic acid supplement above a routine multivitamin level without telling your neurologist.
- Have your phenytoin level rechecked a few weeks after any folate change, because the nonlinear kinetics make the effect hard to predict.
- If pregnancy is possible, do not skip folate out of fear — plan it with your doctor and monitor levels instead.
- This is a manageable, monitorable interaction — coordinate and check levels rather than avoid folate altogether.